Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Profiling serum biomarkers in patients with COPD: associations with clinical parameters.

Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, De Souza MM, Vessey R, Celli B.

Thorax. 2007 Jul;62(7):595-601. Epub 2007 Mar 13.

2.

Association between lung function and exacerbation frequency in patients with COPD.

Hoogendoorn M, Feenstra TL, Hoogenveen RT, Al M, Mölken MR.

Int J Chron Obstruct Pulmon Dis. 2010 Dec 9;5:435-44. doi: 10.2147/COPD.S13826. Review.

3.

Biomarkers in obstructive respiratory diseases: an update.

Braido F, Bagnasco D, Scichilone N, Santus P, Solidoro P, Di Marco F, Corsico A, Canonica GW.

Panminerva Med. 2012 Jun;54(2):119-27. Review.

PMID:
22525566
4.

Biomarker Development in COPD: Moving From P Values to Products to Impact Patient Care.

Hollander Z, DeMarco ML, Sadatsafavi M, McManus BM, Ng RT, Sin DD.

Chest. 2017 Feb;151(2):455-467. doi: 10.1016/j.chest.2016.09.012. Epub 2016 Sep 29. Review.

PMID:
27693595
5.

The potential value of biomarkers in diagnosis and staging of COPD and exacerbations.

Patel AR, Hurst JR, Wedzicha JA.

Semin Respir Crit Care Med. 2010 Jun;31(3):267-75. doi: 10.1055/s-0030-1254067. Epub 2010 May 21. Review.

PMID:
20496296
6.

Systemic biomarkers in exacerbations of COPD: the evolving clinical challenge.

Koutsokera A, Stolz D, Loukides S, Kostikas K.

Chest. 2012 Feb;141(2):396-405. doi: 10.1378/chest.11-0495. Epub 2011 Aug 11. Review.

PMID:
21835899

Supplemental Content

Support Center